Epilepsy – Ayurved Healing

Shankhini (Canscora decussata): The Rare Bitter Herb for Epilepsy and Nervous Disorders

Rohan Kapoor — Fri, 07 Aug 2026 12:00:00 +0000

Shankhini: A Lesser-Known “Brain Herb” in the Shankhpushpi Tradition

Shankhini is a vernacular name used for Canscora decussata, a plant that modern taxonomic databases generally treat as a synonym of Canscora alata. In Ayurvedic and regional herb practice, this plant has also circulated under the wider Shankhpushpi identity, especially where the name Shankhpushpi is applied to more than one botanical source. For nervous-system work, this identity matters: the classical idea of Shankhpushpi is medhya, meaning supportive to intellect, memory, and mental steadiness, but the actual plant used may differ by region and pharmacopoeial standard.

This article focuses specifically on the Canscora source: Canscora decussata / Canscora alata, known in some records as Shankhini. It is best understood as a regional Shankhpushpi-type herb with traditional nervous-system relevance, not as a casual substitute for every product sold under the Shankhpushpi name.

Botanical Identity and Name Confusion

The Shankhpushpi name has long been shared by several plants in different parts of India. The Ayurvedic Pharmacopoeia of India identifies the official Shankhpushpi whole plant as Convolvulus pluricaulis, while pharmacognosy literature records other regional sources such as Clitoria ternatea, Evolvulus alsinoides, and Canscora decussata. For clinical use, the label should state the botanical name, plant part, and source tradition.

Name in Use	Botanical Identity	Practical Note
Shankhpushpi, official pharmacopoeial source	Convolvulus pluricaulis Choisy	The Ayurvedic Pharmacopoeia of India monograph identifies this as Shankhpushpi whole plant.
Regional Shankhpushpi / Aparajita source	Clitoria ternatea Linn.	Recorded in comparative Shankhpushpi literature as one of the regional plant sources used under the name.
Alternate Shankhpushpi source	Evolvulus alsinoides Linn.	Another plant repeatedly listed in surveys of Shankhpushpi botanical variation.
Shankhini / Bangiya Sankhapusphi / Canscora source	Canscora decussata Schult. & Schult.f.; synonym: Canscora alata	The focus of this article; recorded as Shankhini in some Indian floristic sources and as a Shankhpushpi-type plant in pharmacognosy literature.

Canscora decussata belongs to the Gentianaceae family. Botanical descriptions of the accepted Canscora alata identity describe a small erect annual herb, often with four-winged stems, simple sessile leaves with three prominent nerves, and white flowers borne in terminal cymes. These features help distinguish it from creeping Convolvulus sources and climbing Clitoria sources.

Classical Position: Medhya Rasayana and Apasmara Care

Charaka’s Medhya Rasayana passage names four primary intellect-supporting rasayana drugs: Mandukaparni, Yashtimadhu, Guduchi, and Shankhpushpi. In that passage, Shankhpushpi is given in paste form and is praised especially for medha, the capacity of understanding, retention, and mental clarity. Since Canscora decussata is a regional botanical source used under the Shankhpushpi umbrella, its classical use should be framed through this Shankhpushpi tradition while keeping the botanical identity explicit.

The Ayurvedic Pharmacopoeia monograph for Shankhpushpi gives Convolvulus pluricaulis as the official whole-plant source and lists its properties as madhura-kashaya rasa, guru-laghu-snigdha guna, shita virya, and madhura vipaka. These pharmacopoeial properties should not be copied automatically onto Canscora material unless the physician is intentionally working within a regional Shankhpushpi tradition and has identified the plant source.

In the Ayurvedic management of Apasmara, Charaka describes seizure-like presentations through disturbance of memory, consciousness, mind, and abnormal movements, with Vata, Pitta, Kapha, and combined presentations. The treatment framework includes dosha-based care, appropriate purification where indicated, ghrita and oil-based formulations, reassurance, and protection of the patient from hazards such as water, fire, heights, and uneven places. Within that framework, Shankhini is best placed as a supervised medhya support, not as a stand-alone emergency treatment.

Constituents and Nervous-System Relevance

Chemical studies of Canscora decussata identify mangiferin and scopoletin as useful phytomarkers for extracts of the plant. Decussatin, a xanthone compound, is also recorded from Canscora decussata. This xanthone-rich profile gives a pharmacological reason for the traditional attention given to Canscora-type Shankhpushpi material.

A preclinical rat electroshock model evaluated dried whole-plant powder and alcoholic extract of Canscora decussata and reported anticonvulsant activity in that experimental setting. Mangiferin, one of the phytomarkers associated with Canscora extracts, has also been evaluated separately in a pentylenetetrazole-induced mouse seizure model. These findings support the traditional nervous-system interest in the plant while still leaving clinical decisions to a qualified practitioner, especially when a patient is already taking anti-seizure medicine.

Traditional Preparations and Practical Use

Every preparation begins with correct identification. A product or raw herb labelled only as “Shankhpushpi” or “Shankhini” is not precise enough for nervous-system care. The physician or supplier should be able to confirm whether the material is Convolvulus pluricaulis, Clitoria ternatea, Evolvulus alsinoides, or Canscora decussata / Canscora alata.

Shankhini Powder

The FSSAI advisory list includes Canscora decussata leaf under Bangiya/Sankhapusphi and gives 2–4 g as powder. For an individual patient, that range should still be adjusted by a qualified practitioner according to age, digestion, constitution, concurrent medicines, and the purpose of use. Powder is usually the most practical form when fresh plant material is not available, but it requires careful sourcing because the Shankhpushpi name is botanically variable.

Fresh Paste or Juice

Charaka’s Medhya Rasayana passage uses Shankhpushpi in paste form. When Canscora is chosen as the Shankhpushpi-type source, a fresh paste or juice should be prepared only from clean, botanically authenticated material and used under supervision. The anupana, timing, and duration should be chosen by the practitioner rather than copied from a general tonic recipe.

Shankhini Ghrita

Ghrita is relevant in Apasmara care because the classical treatment chapter includes several ghee and oil-based preparations, and Ayurvedic pharmacy describes Sneha Kalpana as a method for processing herbs into a fat medium. When no special formula ratio is given, a common Sneha Kalpana proportion is 1 part herbal paste, 4 parts ghee or oil, and 16 parts liquid.

Kalka: 1 part authenticated Shankhini or Shankhpushpi-type herbal paste, as selected by the practitioner.
Sneha: 4 parts cow’s ghee, or another fat medium selected for the case.
Drava: 16 parts liquid, such as water, decoction, fresh juice, or milk, depending on the formulation logic.
Method: Cook gently with regular stirring until the watery portion is removed and the medicated ghee reaches the proper endpoint.

Classical pharmacy signs for completion include the herbal paste rolling into a wick-like form, absence of watery crackling, and the desired colour, odour, and taste of the finished sneha. Low heat and regular stirring are important so the paste does not burn.

A Safe Support Protocol for Apasmara

For epilepsy or recurrent seizures, continuity of medical care is the first rule. Shankhini should not replace prescribed anti-seizure medicines. It may be considered only as complementary medhya support when the neurologist and qualified Ayurvedic practitioner both know what the patient is taking.

Care Area	How It Is Applied	Purpose
Medical supervision	Continue prescribed anti-seizure medicines exactly as directed unless the treating doctor changes them.	Prevents unsafe withdrawal, missed-dose seizures, and sudden medication changes.
Ayurvedic assessment	Assess Vata, Pitta, Kapha, digestion, sleep, mental stress, and strength before choosing any herb or ghrita.	Places Shankhini within a complete Apasmara support plan rather than using it in isolation.
Botanical authentication	Use Canscora only when the material is identified as Canscora decussata / Canscora alata.	Avoids mixing different Shankhpushpi sources without clinical intention.
Medhya support	Use powder, paste, juice, or ghrita only in the dose and form selected by the practitioner.	Supports memory, steadiness, and nervous-system resilience within the classical medhya framework.
Safety planning	Protect the patient around water, bathing, swimming, fire, heights, driving, and uneven places.	Reduces injury risk during unpredictable seizure episodes.
Review	Track seizure pattern, sleep, missed doses, diet changes, adverse effects, and any new supplements.	Helps the care team judge whether the plan remains appropriate.

Any change in seizure frequency, awareness, injury risk, medicine tolerance, or mental state should be discussed promptly with the treating clinician. Conventional anti-seizure medicines should never be reduced or stopped suddenly for an herbal trial.

Dietary and Lifestyle Support for Nervous System Stability

Ayurvedic care for Apasmara emphasizes steadiness: clean food, regular habits, mental calm, and avoidance of factors that disturb the mind and doshas. Charaka connects Apasmara with unsuitable food and emotional disturbances such as worry, fear, anger, grief, and anxiety. Modern seizure care also gives importance to taking medicines as prescribed and avoiding individual triggers such as sleep loss, missed meals, alcohol, or missed medication.

Favor: Freshly cooked meals, steady meal timing, adequate sleep, calm daily rhythm, and practitioner-selected ghrita or medhya support when suitable.
Avoid: Missed anti-seizure medicines, sudden medication changes, alcohol, recreational drugs, sleep deprivation, skipped meals, and known personal seizure triggers.
Practice: Gentle breathing, meditation, family education, and a practical safety plan, provided these practices are comfortable and do not provoke symptoms.

Conservation and Responsible Sourcing

Canscora decussata has been described in plant tissue-culture literature as a threatened medicinal herb, with propagation work proposed for conservation and sustainable supply. This makes responsible sourcing important. Prefer cultivated, authenticated, or sustainably collected material, and avoid products that provide only a loose market name without botanical identity, plant part, and batch information.

A Word on Safety

Shankhini is a potent medicinal herb used within a complex clinical context. People with epilepsy, recurrent fainting, unexplained loss of consciousness, psychiatric symptoms, liver or kidney disease, pregnancy, lactation, childhood use, or multiple prescription medicines should not self-prescribe it. Anyone taking phenytoin, carbamazepine, valproate, levetiracetam, clobazam, or any other anti-seizure medicine should consult their neurologist before adding Canscora, Shankhpushpi, ghrita, or any medhya formulation.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Epilepsy and recurrent seizures require professional medical diagnosis and management. Never reduce, skip, or discontinue anti-seizure medicines without your doctor’s guidance. Use Shankhini or any Ayurvedic seizure-support protocol only under the care of a qualified Ayurvedic practitioner and a licensed healthcare provider.

References

Apasmara (Epilepsy) in Ayurveda: Classical Pathophysiology and Non-Pharmacological Support

Dr. Ananya Sharma — Tue, 02 Jun 2026 06:00:00 +0000

Families living with epilepsy often ask a careful and reasonable question: can Ayurveda support sleep, stress management, appetite, cognition, or medication tolerability while neurological treatment continues? That is a safer question than asking Ayurveda to replace antiseizure medicine. Sodium valproate, for example, can control several seizure types, but recognised adverse effects include weight gain, hair thinning or texture changes, and tremor. Persistent adverse effects deserve review by the prescribing neurologist rather than an unsupervised dose reduction.

Classical Ayurveda discusses episodic loss of awareness and abnormal movements under Apasmara. The descriptions overlap with some seizure presentations, but Apasmara is not a validated one-to-one synonym for every modern epilepsy syndrome. Modern diagnosis depends on seizure history, neurological examination, EEG and, when indicated, imaging and other tests. Ayurvedic assessment may be used as a complementary framework, not as a substitute for neurological classification.

Critical safety disclaimer: Epilepsy is a serious neurological condition. Never stop, reduce, skip, or switch an antiseizure medicine because of information in this article. Sudden withdrawal can allow seizures to recur. Any herb, medicated ghee, supplement, fasting practice, cleansing procedure, nasal preparation, or major dietary change should be discussed with the treating neurologist and a qualified Ayurvedic physician who has the complete medication list. Children and adolescents require especially close supervision.

The Classical Definition of Apasmara

Charaka Samhita places Apasmara Nidana in Nidana Sthana Chapter 8 and its treatment in Chikitsa Sthana Chapter 10. Chikitsa 10/3 describes Apasmara as loss or departure of smriti, accompanied by entry into darkness or blackout and disturbing involuntary activity, arising with disturbance of dhi and sattva. Sushruta Samhita, Uttara Tantra Chapter 61, explains the name through deprivation of smriti, the faculty connected with past cognition.

These passages should be read in their own intellectual setting. In classical Ayurveda, hridaya is discussed as a seat of consciousness and mind; it should not be translated as a precise equivalent of the limbic system, brainstem, or any single modern anatomical structure. Similarly, smriti, dhi, sattva, rajas, and tamas are classical functional concepts, not modern neurotransmitters or brain regions.

Four Classical Types Without Forced Modern Mapping

Charaka describes four dosha-based forms: Vata-dominant, Pitta-dominant, Kapha-dominant, and Sannipatika or Tridoshaja. The features below are translations of the classical descriptions, not diagnostic equivalents of absence, focal, myoclonic, or tonic-clonic epilepsy. A modern seizure type must not be assigned from foam colour, perceived colours, body temperature, or recovery speed.

Classical Type	Features Described in Charaka Chikitsa 10	Appropriate Modern Interpretation
Vatika Apasmara	Trembling, grinding of teeth, frothing, gasping, and perceptions described as rough, reddish-brown, or dark.	A classical dosha pattern only; it does not identify a modern seizure syndrome.
Paittika Apasmara	Yellowish appearance or froth, thirst, heat sensation, and perceptions of yellow, blood-red, or fiery forms.	A classical dosha pattern only; autonomic symptoms require neurological assessment.
Kaphaja or Shlaishmika Apasmara	Whitish froth or appearance, coldness, heaviness or stiffness, perceptions of white forms, and delayed recovery.	A classical dosha pattern only; prolonged impaired awareness can be an emergency.
Sannipatika or Tridoshaja Apasmara	A mixture of the features attributed to all three doshas.	Classically described as difficult or incurable, but this prognosis must not replace modern evaluation.

Classical Causation and Pathogenesis

Charaka links Apasmara with aggravated bodily doshas, impairment by rajas and tamas, unsuitable or impure food, irregular conduct, depletion, and intense mental states such as worry, fear, anger, grief, desire, and agitation. The text then describes the doshas affecting the channels associated with hridaya and the senses, followed by bewilderment, falling, tremulous movements, salivation, limb movements, and eventual recovery “as if waking from sleep.”

This is a classical explanatory model, not a modern account of neuronal electrical discharge. Stress and poor sleep can be reported seizure triggers in some people, but they do not prove that emotion alone caused epilepsy. Not every event that resembles a seizure is epilepsy, so diagnosis belongs with clinicians trained in seizure disorders.

What “Medhya Rasayana” Actually Means

Medhya Rasayana refers to classical measures intended to support intellect and memory. Charaka’s Rasayana section specifically names Mandukaparni, Yashtimadhu, Guduchi, and Shankhapushpi in this context. That category should not be converted into a claim that these herbs prevent seizures. Classical indication, laboratory pharmacology, animal anticonvulsant activity, and proven clinical seizure control are four different levels of evidence.

Brahmi and Brahmi Ghrita

The Ayurvedic Pharmacopoeia of India identifies Brahmi whole plant as Bacopa monnieri. Human studies of Bacopa have examined memory and cognition, while much of the epilepsy-related literature is preclinical or review-based. There is no reliable basis for presenting a standard Bacopa extract dose as an established adjunctive epilepsy treatment. Gastrointestinal adverse effects and product variability still need individual review.

Charaka Chikitsa 10/25 describes an old ghee processed with Brahmi juice, Vacha, Kushtha, and Shankhapushpi. This verifies that a Brahmi-containing ghee formulation appears in the classical Apasmara chapter; it does not verify the modern claims that ghee increases “CNS penetration,” that one teaspoon at bedtime is universally appropriate, or that the formula is safe to prepare at home. Botanical identity, processing, dose, quality testing, age, digestion, comorbidities, and concurrent medicines all matter.

Shankhapushpi

The Ayurvedic Pharmacopoeia identifies Shankhapushpi as the whole plant of Convolvulus pluricaulis, gives it classical medhya and rasayana actions, lists Manasaroga and Apasmara among therapeutic uses, and notes that Clitoria ternatea and Evolvulus alsinoides are used under the same name in some regions. This identity variation is one reason a common name on a bottle is not enough for safe prescribing.

A published report investigated a clinically important interaction between a Shankhapushpi-containing Ayurvedic preparation and phenytoin after reduced phenytoin levels and loss of seizure control were observed in two patients; subsequent rat experiments also found reduced phenytoin activity and levels with repeated coadministration. The authors advised against the clinical combination. This does not establish that every Shankhapushpi product behaves identically, but it strongly supports specialist review rather than self-medication.

Ashwagandha

Ashwagandha is frequently marketed for “brain health,” but marketing language is not epilepsy evidence. NCCIH states that ashwagandha may cause drowsiness and gastrointestinal effects, has been linked rarely with liver injury, and may interact with anticonvulsants and sedatives. Animal or cell studies of neuroinflammation cannot justify a branded extract dose for a child or adult with epilepsy.

Classical Procedures Are Not Home Remedies

Charaka’s Apasmara treatment chapter includes strong purification procedures selected by dosha, reassurance or counselling, medicated ghees, external applications, and nasal formulations. These are physician-directed classical interventions rather than home remedies. Vamana, virechana, basti, medicated nasya, and complex ghees require direct clinical supervision. They should not be attempted during unstable seizure control or without coordinated specialist care.

The original claim that Shirodhara is the primary classical Panchakarma treatment for Apasmara, together with a fixed 30–45 minute course for 7–14 days, is not supported by the cited Charaka chapter. Shirodhara may be used in contemporary Ayurvedic practice for relaxation, but evidence that it prevents epileptic seizures is insufficient. Likewise, daily home nasya with four drops of Brahmi Ghrita is not a verified universal protocol and should not be recommended without examination and supervision.

Lifestyle Measures With the Strongest Practical Basis

Daily routine can support seizure management, but it works alongside—not instead of—prescribed treatment. The most useful plan is individualized and recorded in a seizure diary so that suspected triggers can be compared with actual events.

Take medicines consistently: missed or late doses and unsupervised dose changes can increase seizure risk.
Protect sleep: insufficient or disrupted sleep is a commonly reported trigger, and it is particularly relevant in juvenile myoclonic epilepsy.
Limit alcohol and avoid recreational drugs: heavy alcohol use, withdrawal, and several recreational drugs can precipitate seizures.
Eat regularly and stay hydrated: skipping meals or low blood glucose may be a trigger for some people, but fixed meal times are not a universal epilepsy prescription.
Identify personal sensory triggers: flashing lights or patterns matter mainly for people with photosensitive epilepsy; ordinary screen use is not a trigger for everyone.
Exercise safely: walking, yoga, sports, and resistance exercise may support general health. Choice and intensity should reflect seizure control, supervision, heat exposure, swimming safety, and the neurologist’s advice rather than a blanket ban on vigorous activity.

Seizure First Aid Belongs in Every Integrative Plan

A household plan is more protective than any unproven supplement. During a convulsive seizure, ease the person to the ground if needed, clear nearby hazards, cushion the head, loosen tight clothing around the neck, turn the person gently onto one side when possible, and time the event. Do not restrain the person and do not put food, water, medicine, fingers, or objects into the mouth.

Seek emergency help when a seizure lasts five minutes or longer, repeats without recovery, causes breathing difficulty or injury, occurs in water, is a first seizure, or the person does not return toward their usual state. Follow any individualized rescue-medicine plan supplied by the treating clinician.

A Realistic Scope for Ayurveda

The responsible role for Ayurveda is supportive and individualized: improving routine, sleep hygiene, digestion, nutrition, stress coping, caregiver confidence, and quality of life while avoiding products or procedures that destabilize seizure control. No Ayurvedic herb has been conclusively shown in people with epilepsy to be both safe and effective as a seizure treatment, and “natural” products can weaken antiseizure medicines or provoke adverse effects.

When medication side effects are troublesome, the appropriate response is a structured review: document seizure control, timing of adverse effects, sleep, weight, mood, cognition, other medicines, and all supplements; then discuss options with the neurologist. A qualified Ayurvedic physician can contribute after receiving the diagnosis, seizure type, EEG summary, laboratory information when relevant, and complete medication list.

Consult the treating neurologist and a qualified Ayurvedic practitioner before beginning any herbal, ghee-based, nasal, cleansing, fasting, or dietary protocol for epilepsy. Herb–drug interactions and delayed medical care can be serious.